Yanbin Kuang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Advances in translational lung cancer research in 2025: a narrative review.
Journal: Translational lung cancer research
Published: February 27, 2026
SMARCA4-deficient thoracic tumors exhibit an immunosuppressive microenvironment and respond to combined antiangiogenic and immune checkpoint inhibitor therapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 04, 2025
Biomimetic 3D-Bioprinted organoids of thymic epithelial tumors for translational drug screening and biomarker identification.
Journal: Materials today. Bio
Published: October 30, 2025
Hinokitiol preferentially suppresses metastatic lung adenocarcinoma via TMDD1-mediated ferroptosis induction and iron-sulfur cluster inhibition.
Journal: Cancer letters
Published: June 29, 2025
Immune-related cardiotoxicities predict immune checkpoint inhibitors treatment for advanced non-small cell lung cancer: a retrospective multi-center study.
Journal: Journal of thoracic disease
Published: February 26, 2025
The novelty of profilin 2 in regulating pyruvate kinase M2 nuclear translocation and promoting tumor angiogenesis in lung adenocarcinoma.
Journal: Respiratory research
Published: September 27, 2024
Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage study.
Journal: BMC cancer
Published: March 03, 2024
Efficacy and safety analysis of anlotinib combined with PD-1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study.
Journal: Journal of thoracic disease
Published: February 13, 2023
Last Updated: 09/26/2026